In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal expands

This article was originally published in The Rose Sheet

Executive Summary

Firm announces April 12 that it has fully acquired professional salon distributor Beauty Alliance in an effort to strengthen its U.S. professional hair-care business; L'Oreal acquired a 30% minority interest in the distributor in July. Beauty Alliance, which comprises 870 distributor sales consultants and 400 professional outlets selling to 125,000 salons, will operate as a separate unit within L'Oréal's professional products division. Separately, L'Oréal announces first-quarter sales, with consumer product sales increasing 8.2% on a like-for-like basis to $2.92 bil. on the strength of Garnier, L'Oréal Paris and Maybelline, while The Body Shop recorded sales growth of 6.4% to $229.9 mil. Professional products advanced 7.5% to $736.2 mil. Net cosmetic sales were $5.47 bil., representing 8% growth...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014671

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel